The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Influvac Tetra, suspension for injection in pre-filled syringe (influenza vaccine, surface antigen, inactivated)



Viatris Healthcare LimitedPA23355/016/001

Main Information

Trade NameInfluvac Tetra, suspension for injection in pre-filled syringe (influenza vaccine, surface antigen, inactivated)
Active SubstancesA/Victoria/2570/2019 (H1N1)pdm09 - like strain (A/Victoria/2570/2019, IVR-215)
A/Thailand/8/2022 (H3N2)-like strain (A/California/122/2022, SAN-022)
B/PHUKET/3073/2013 -LIKE STRAIN (B/PHUKET/3073/2013, WILD TYPE)
B/Austria/1359417/2021 - like strain (B/Michigan/01/2021, wild type)
Dosage FormSuspension for injection in pre-filled syringe
Licence HolderViatris Healthcare Limited
Licence NumberPA23355/016/001

Group Information

ATC CodeJ07BB Influenza vaccines
J07BB02 influenza, inactivated, split virus or surface antigen

Status

License statusAuthorised
Licence Issued25/08/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back